$4.58Average Price Target
The highest estimate is 8.25.
From 3 ratings within the last 6 months. This is not an investment recommendation.
This list is based on the watchlists of people on Stock Events who follow LUCD.BOATS. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an esophageal cell collection device. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.
Show more...
FAQ
What is Lucid Diagnostics stock price today?▼
The current price of LUCD.BOATS is $1.17 USD — it has decreased by -2.5% in the past 24 hours. Watch Lucid Diagnostics stock price performance more closely on the chart.
What is Lucid Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Lucid Diagnostics stocks are traded under the ticker LUCD.BOATS.
What is Lucid Diagnostics market cap?▼
Today Lucid Diagnostics has the market capitalization of 161.09M
When is the next Lucid Diagnostics earnings date?▼
Lucid Diagnostics is going to release the next earnings report on May 18, 2026.
What were Lucid Diagnostics earnings last quarter?▼
LUCD.BOATS earnings for the last quarter are -0.1 USD per share, whereas the estimation was -0.09 USD resulting in a -8.11% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Lucid Diagnostics revenue for the last year?▼
Lucid Diagnostics revenue for the last year amounts to 8.69M USD.
What is Lucid Diagnostics net income for the last year?▼
LUCD.BOATS net income for the last year is -106.05M USD.
When did Lucid Diagnostics complete a stock split?▼
Lucid Diagnostics has not had any recent stock splits.